Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 2741 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Monitoring Tacrolimus Trough Concentrations During the First Year After Kidney Transplantation: A National Retrospective Cohort Study
Sarah S. Alghanem,Moetaza M. Soliman,Ali A. Alibrahim,Osama Gheith,Ahmed S. Kenawy,Abdelmoneim Awad
Frontiers in Pharmacology.2020;11()
[DOI]
2Long-term efficacy and safety of anti-hyperglycaemic agents in new-onset diabetes after transplant: Results from outpatient-based 1-year follow-up and a brief review of treatment options
Debmalya Sanyal,Mansij Biswas,Nayan Chaudhari
Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2021;15(1)13
[DOI]
3Risk factors for new-onset diabetes mellitus after kidney transplantation: A systematic review and meta-analysis
Mancheng Xia,Haosen Yang,Xunan Tong,Hongjie Xie,Fan Cui,Weibing Shuang
Journal of Diabetes Investigation.2021;12(1)109
[DOI]
4Influencing Factors of Blood Glucose Changes in Patients with Abnormal Glucose Metabolism after Kidney Transplantation
? ?
Advances in Clinical Medicine.2020;10(06)997
[DOI]
5Evaluation of Tacrolimus Trough Level in Patients Who Developed Post-transplant Diabetes Mellitus After Kidney Transplantation: A Retrospective Single-Center Study in Saudi Arabia
Alyaa Ajabnoor,Mohannad Nasser,Naveed Khan,Wael Habhab
Transplantation Proceedings.2020;52(10)3160
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal